Literature DB >> 30703512

Lung Stereotactic Arc Therapy in Mice: Development of Radiation Pneumopathy and Influence of HIF-1α Endothelial Deletion.

Jérémy Lavigne1, Alexandra Suissa2, Nicolas Verger2, Morgane Dos Santos3, Mohamedamine Benadjaoud4, Laurence Mille-Hamard5, Iman Momken5, Frédéric Soysouvanh1, Valérie Buard2, Olivier Guipaud2, Vincent Paget2, Georges Tarlet2, Fabien Milliat2, Agnès François6.   

Abstract

PURPOSE: Stereotactic body radiation therapy offers good lung local tumor control by the administration of a high dose per fraction in small volumes. Stereotactic body radiation therapy preclinical modeling is now possible, and our aim was to develop a model of focal irradiation of the mouse lung and to investigate the impact of conditional hypoxia-inducible factor 1α (HIF-1α) deletion in the endothelium on radiation-induced tissue damage. METHODS AND MATERIALS: The Small Animal Radiation Research Platform was used to create a mouse model of focal irradiation of the lung using arc therapy. HIF-1α conditional deletion was obtained by crossing mice expressing Cre recombinase under the endothelial promoter VE-cadherin (VECad-Cre+/+ mice) with HIF-1α floxed mice.
RESULTS: Lung stereotactic arc therapy allows thoracic wall sparing and long-term studies. However, isodose curves showed that neighboring organs received significant doses of radiation, as revealed by ipsilateral lung acute red hepatization and major gene expression level modifications. Conditional HIF-1α deletion reduced acute lung edema and tended to diminish neutrophil infiltrate, but it had no impact on long-term global tissue damage.
CONCLUSIONS: Arc therapy for focal high-dose irradiation of mouse lung is an efficient model for long-term studies. However, irradiation may have a strong impact on the structure and function of neighboring organs, which must be considered. HIF-1α conditional deletion has no beneficial impact on lung damage in this irradiation schedule.
Copyright © 2019. Published by Elsevier Inc.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30703512     DOI: 10.1016/j.ijrobp.2019.01.081

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  5 in total

Review 1.  Novel treatment planning approaches to enhance the therapeutic ratio: targeting the molecular mechanisms of radiation therapy.

Authors:  M Protopapa; V Kouloulias; A Kougioumtzopoulou; Z Liakouli; C Papadimitriou; A Zygogianni
Journal:  Clin Transl Oncol       Date:  2019-06-28       Impact factor: 3.405

2.  Exploring the Pharmacological Mechanism of Radix Salvia Miltiorrhizae in the Treatment of Radiation Pneumonia by Using Network Pharmacology.

Authors:  Peng Li; Xiaochun Xia; Jundong Zhou; Jinchang Wu
Journal:  Front Oncol       Date:  2021-07-29       Impact factor: 6.244

3.  Preclinical Model of Stereotactic Ablative Lung Irradiation Using Arc Delivery in the Mouse: Is Fractionation Worthwhile?

Authors:  Annaïg Bertho; Morgane Dos Santos; Sarah Braga-Cohen; Valérie Buard; Vincent Paget; Olivier Guipaud; Georges Tarlet; Fabien Milliat; Agnès François
Journal:  Front Med (Lausanne)       Date:  2021-12-24

Review 4.  Radiotherapy-immunotherapy combinations - perspectives and challenges.

Authors:  Michele Mondini; Antonin Levy; Lydia Meziani; Fabien Milliat; Eric Deutsch
Journal:  Mol Oncol       Date:  2020-03-13       Impact factor: 6.603

Review 5.  A Rosetta Stone for Breast Cancer: Prognostic Value and Dynamic Regulation of Neutrophil in Tumor Microenvironment.

Authors:  Wei Zhang; Yimin Shen; Huanhuan Huang; Sheng Pan; Jingxin Jiang; Wuzhen Chen; Ting Zhang; Chao Zhang; Chao Ni
Journal:  Front Immunol       Date:  2020-08-07       Impact factor: 8.786

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.